Evidence map›Paper›PMID 41627727›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Why Euglenozoans.

Michael L Ginger, Anna Karnkowska, Laura-Isobel McCall, Ariel M Silber, Paul A M Michels

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael L GingerSchool of Applied Sciences, University of Huddersfield, Huddersfield, UK. M.Ginger@hud.ac.uk.
Anna KarnkowskaInstitute of Evolutionary Biology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Laura-Isobel McCallDepartment of Chemistry and Biochemistry, San Diego State University, San Diego, CA, USA.
Ariel M SilberLaboratory of Biochemistry of Trypanosomatids (LaBTryps), Department of Parasitology, Institute of Biomedical Science II, University of São Paulo, Butantã, São Paulo, SP, Brazil.
Paul A M MichelsSchool of Biological Sciences, The University of Edinburgh, Edinburgh, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To accompany a new collection of methods and protocols, we discuss the relevance of the microbial eukaryotes belonging to the protist phylum Euglenozoa. For those interested by Euglena, applied biology is often relevant: as a starting point for useful natural products including biofuels, nutritional supplements, and metabolites with biomedical potential, or as an environmental agent for bioremediation. Arguably the most widely studied euglenozoans are the parasitic trypanosomatids. Collectively, trypanosomatids cause several serious neglected tropical diseases and economically important diseases of animals and plants; since the early 1900s, drug discovery and disease intervention have been prominent research areas. Yet for those interested in evolution, trypanosomatids and Euglena are host to all sorts of extreme biology either not seen or so pronounced in other eukaryotes. Euglenozoans are also relevant in an ecology context: free-living relatives of the trypanosomatids are abundant in freshwater environments. Moreover, the other major euglenozoan group, the diplonemids, are recently recognized as the most abundant heterotrophic protists in the world's oceans, their diversity and abundance at least comparable to major algal groups. Finally, the long history of euglenozoan study illustrates nicely the evolving nature of scientific discovery and reporting since Van Leeuwenhoek first saw Euglena in the pioneering days of microscopy.

Indexed as

EuglenozoaAnimalsDiplonemaEuglena gracilisKinetoplastKinetoplastidLeishmaniaMicrobial ecologyMitochondrial DNANeglected tropical diseasesTrypanosoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.